En

The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC)

The Biological and Medicinal Chemistry Sector (BMCS) of the Royal Society of Chemistry (RSC)

Mission

The Biological and Medicinal Chemistry Sector (BMCS) aims to further the interests of all members of the RSC, industrial and academic, involved in the pursuit and understanding of biologically active molecules. It also acts to promote public awareness of the crucial role played by chemistry in the modern industrial environment. 

Founded

1995 (Formerly Fine Chemicals & Medicinals Group)

Members

2089

Member profile

Academia + Industry

Postal address

19 Shakespeare Road
CT7 9ET Birchington United Kingdom

Phone number

+44 1843 845783 / 7962 929700

Website

Activities

The BMCS is an interest group of the Royal Society of Chemistry (RSC) in the UK. The elected committee is primarily responsible for the organisation of scientific meetings and symposia, supporting education and training in medicinal chemistry in the UK, and advising the RSC on policies that directly affect the BMCS. The predominant areas include pharmaceuticals and agrochemicals, and we also have strong links to chemical biology. The BMCS acts to promote public awareness of the crucial role played by chemistry in the modern industrial environment.

The BMCS is particularly active in the organisation of scientific meetings and does so in collaboration with a wide variety of other learned societies both within and external to the RSC. We typically run several meetings each year jointly with the Society for Chemical Industry but we have also held or plan to hold internationally attended meetings with other learned societies. Any surplus from our meetings is reinvested to support educational activities at both primary and secondary school level, such as running lectures and day schools, and the provision of equipment.

The BMCS administers two biennial awards, the Malcolm Campbell Award and the Capps-Green-Zomaya Award, which acknowledge major scientific achievements in both academia and industry that have been carried out within the UK and Europe. In addition the BMCS supports medicinal chemistry at universities by funding a ‘BMCS Lectureship’ and travel bursaries for UK-based postgraduate students to allow attendance at international symposia. We have recently set up a ‘Medicinal Chemistry Hall of Fame’ which saw Sir Robin Ganellin as the first inductee – nominations for this are welcome at any time – and ‘Researcher Mobility Fellowships’ to further recognise and support our community.

  • 3rd RSC / SCI Symposium on Antimicrobial Drug Discovery
    (November 15-16, 2021), Virtual event
  • Postgraduate Symposium XV - Biological and Medicinal Chemistry Symposium for Postgraduates
    (December 10, 2021), Online Event
  • 5th RSC / DMDG / DMG New Perspectives in DMPK
    (February 22-23, 2022), Liverpool, United Kingdom
  • Fragments VIII: 8th RSC-BMCS Fragment-based Drug Discovery meeting
    (March 27-28, 2022), Churchill College, Cambridge, UK and virtual
  • 33rd Medicinal Chemistry in Eastern England (Hatfield symposium)
    (April 28, 2022), The Fielder Centre, Hatfield, UK
  • 2nd Synthesis in Drug Discovery and Development meeting
    (May 4-5, 2022), Virtual event
  • 5th RCS-BMCS /RSC-CICAG Artificial Intelligence in Chemistry
    (September 1-2, 2022), Churchill College, Cambridge and virtual
  • 8th RSC/SCI symposium on GPCRs in Medicinal Chemistry
    (October 5-7, 2022), Verona, Italy
  • Postgraduate symposium XVI
    (December 9, 2022), University of Oxford, Oxford, UK
  • 9th RSC / SCI Kinase Symposium on Inhibitor Design
    (May 9-10, 2023), SCI, London, UK
  • 3rd RSC Anglo-Nordic Medicinal Chemistry Symposium
    (June 13-16, 2023), Hotel Comwell Borupgaard, Snekkersten, Denmark

President

Dr WILLIAMS Andrew (Eli Lilly & Co.)

Secretary

Dr AHMAD Nadia (Charles River)

Treasurer

Dr WILLIAMSON Douglas (Vernalis)

EFMC-Delegate

Dr ALKER David (David Alker Associates)